Open AccessAblation of lysophosphatidic acid receptor 1 attenuates hypertrophic cardiomyopathy in a mouse model
Author(s) -
Anna Axelsson Raja,
Hiroko Wakimoto,
Daniel M. DeLaughter,
Daniel Reichart,
Joshua M. Gorham,
David A. Conner,
Mingyue Lun,
Clemens K. Probst,
Norihiko Sakai,
Rachel S. Knipe,
Sydney B. Montesi,
Barry S. Shea,
Leonard P. Adam,
Leslie A. Leinwand,
William Wan,
Esther Choi,
Eric L. Lindberg,
Giannino Patone,
Michela Noseda,
Norbert Hübner,
Christine Seidman,
Andrew M. Tager,
Carolyn Y. Ho
Publication year - 2022
Publication title -
proceedings of the national academy of sciences of the united states of america
Language(s) - English
Resource type - Journals
eISSN - 1091-6490
pISSN - 0027-8424
DOI - 10.1073/pnas.2204174119
Subject(s) - lysophosphatidic acid , fibrosis , hypertrophic cardiomyopathy , myocardial fibrosis , cancer research , biology , microbiology and biotechnology , pathology , medicine , receptor